BindingDB logo
myBDB logout

Patent code US10919884

Compile Data Set for Download or QSAR
Found 8 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Complement factor D


(Homo sapiens (Human))
BDBM482848
PNG
(5-(3,3- difluoropiperidine- 1-carboxamido)-1- (2-(...)
Show SMILES Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(NC(=O)N4CCCC(F)(F)C4)ccc23)n1
Show InChI InChI=1S/C30H34F3N7O4/c1-18-4-2-5-25(35-18)37-28(43)24-8-6-19(31)10-13-40(24)26(41)16-39-15-22(27(34)42)21-14-20(7-9-23(21)39)36-29(44)38-12-3-11-30(32,33)17-38/h2,4-5,7,9,14-15,19,24H,3,6,8,10-13,16-17H2,1H3,(H2,34,42)(H,36,44)(H,35,37,43)/t19?,24-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...


US Patent US10919884 (2021)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM482849
PNG
((S)-N5- (cyclopropylsulfonyl)- 1-(2-(6-((6- methyl...)
Show SMILES Cc1cccc(NC(=O)[C@@H]2CC=CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)C(=O)NS(=O)(=O)C2CC2)n1
Show InChI InChI=1S/C27H28N6O6S/c1-16-5-4-7-23(29-16)30-27(37)22-6-2-3-12-33(22)24(34)15-32-14-20(25(28)35)19-13-17(8-11-21(19)32)26(36)31-40(38,39)18-9-10-18/h2-5,7-8,11,13-14,18,22H,6,9-10,12,15H2,1H3,(H2,28,35)(H,31,36)(H,29,30,37)/t22-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...


US Patent US10919884 (2021)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM482850
PNG
(N5- (cyclopropylsulfonyl)- 1-(2-((2R,4R)- 4-fluoro...)
Show SMILES Cc1cccc(CC(O)[C@H]2C[C@@H](F)CN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)C(=O)NS(=O)(=O)C2CC2)n1
Show InChI InChI=1S/C27H30FN5O6S/c1-15-3-2-4-18(30-15)11-24(34)23-10-17(28)12-33(23)25(35)14-32-13-21(26(29)36)20-9-16(5-8-22(20)32)27(37)31-40(38,39)19-6-7-19/h2-5,8-9,13,17,19,23-24,34H,6-7,10-12,14H2,1H3,(H2,29,36)(H,31,37)/t17-,23-,24?/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...


US Patent US10919884 (2021)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM482847
PNG
(5-(3,3- difluoropiperidine- 1-carboxamido)-1- (2-(...)
Show SMILES Cc1cccc(CC(O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2cc(C(N)=O)c3cc(NC(=O)N4CCCC(F)(F)C4)ccc23)n1
Show InChI InChI=1S/C29H33F3N6O4/c1-17-4-2-5-19(34-17)12-25(39)24-10-18(30)13-38(24)26(40)15-37-14-22(27(33)41)21-11-20(6-7-23(21)37)35-28(42)36-9-3-8-29(31,32)16-36/h2,4-7,11,14,18,24-25,39H,3,8-10,12-13,15-16H2,1H3,(H2,33,41)(H,35,42)/t18-,24+,25?/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...


US Patent US10919884 (2021)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM482852
PNG
(N5- (cyclopropylsulfonyl)- 1-(2-((2S)-5-fluoro-2- ...)
Show SMILES Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)C(=O)NS(=O)(=O)C2CC2)n1
Show InChI InChI=1S/C28H31FN6O6S/c1-16-3-2-4-24(31-16)32-28(39)23-10-6-18(29)11-12-35(23)25(36)15-34-14-21(26(30)37)20-13-17(5-9-22(20)34)27(38)33-42(40,41)19-7-8-19/h2-5,9,13-14,18-19,23H,6-8,10-12,15H2,1H3,(H2,30,37)(H,33,38)(H,31,32,39)/t18?,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...


US Patent US10919884 (2021)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM482820
PNG
((S)-5-(3,3- difluoropiperidine- 1-carboxamido)-1- ...)
Show SMILES Cc1cccc(NC(=O)[C@@H]2CC=CCN2C(=O)Cn2cc(C(N)=O)c3cc(NC(=O)N4CCCC(F)(F)C4)ccc23)n1
Show InChI InChI=1S/C29H31F2N7O4/c1-18-6-4-8-24(33-18)35-27(41)23-7-2-3-13-38(23)25(39)16-37-15-21(26(32)40)20-14-19(9-10-22(20)37)34-28(42)36-12-5-11-29(30,31)17-36/h2-4,6,8-10,14-15,23H,5,7,11-13,16-17H2,1H3,(H2,32,40)(H,34,42)(H,33,35,41)/t23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...


US Patent US10919884 (2021)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM482846
PNG
(5-(3,3- difluoropiperidine- 1-carboxamido)-1- (2-(...)
Show SMILES Cc1cccc(CC(O)[C@H]2C[C@@H](F)CN2C(=O)Cn2cc(C(N)=O)c3cc(NC(=O)N4CCCC(F)(F)C4)ccc23)n1
Show InChI InChI=1S/C29H33F3N6O4/c1-17-4-2-5-19(34-17)12-25(39)24-10-18(30)13-38(24)26(40)15-37-14-22(27(33)41)21-11-20(6-7-23(21)37)35-28(42)36-9-3-8-29(31,32)16-36/h2,4-7,11,14,18,24-25,39H,3,8-10,12-13,15-16H2,1H3,(H2,33,41)(H,35,42)/t18-,24-,25?/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...


US Patent US10919884 (2021)

More data for this
Ligand-Target Pair
Complement factor D


(Homo sapiens (Human))
BDBM482851
PNG
(N5- (cyclopropylsulfonyl)- 1-(2-((2S,4R)- 4-fluoro...)
Show SMILES Cc1cccc(CC(O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)C(=O)NS(=O)(=O)C2CC2)n1
Show InChI InChI=1S/C27H30FN5O6S/c1-15-3-2-4-18(30-15)11-24(34)23-10-17(28)12-33(23)25(35)14-32-13-21(26(29)36)20-9-16(5-8-22(20)32)27(37)31-40(38,39)19-6-7-19/h2-5,8-9,13,17,19,23-24,34H,6-7,10-12,14H2,1H3,(H2,29,36)(H,31,37)/t17-,23+,24?/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Achillion Pharmaceuticals, Inc.

US Patent


Assay Description
Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...


US Patent US10919884 (2021)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%